Search - tctmd.com

Displaying 101 - 120 of 142

Sort: Relevancy | Date

News Industry News

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

September 08, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Daily News

美国的女性介入医生依然很罕见

Yael L. Maxwell

August 21, 2015

News Daily News

Las Mujeres Intervencionistas Siguen Siendo una Rareza en EE.UU.

Yael L. Maxwell

August 21, 2015

News Daily News

Female Interventionalists Remain a Rarity in the United States

Yael L. Maxwell

August 21, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Industry News

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

July 21, 2015

News Industry News

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

June 22, 2015

News Industry News

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

June 09, 2015

News Industry News

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

June 04, 2015

News Industry News

India Coronary Stent Market to be Tripled by 2021

May 05, 2015

News Daily News

医保患者接受颈动脉支架置入后的高死亡率可能会影响治疗益处

January 28, 2015

News Daily News

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

January 28, 2015

News Conference News TCT 2014

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

September 14, 2014

News Conference News TCT 2014

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

September 14, 2014

News Daily News

过去十年中避免或经受住急性CVD、卒中的前景大为改善

September 02, 2014

News Daily News

Outlook for Avoiding or Surviving Acute CVD, Stroke Much Improved Over Past Decade

September 02, 2014

News Daily News

MI患者的低试验参与率引起了对适用性的质疑

Todd Neale

September 02, 2014

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Daily News

El Bajo Índice de Participación del Ensayo de Pacientes IM Plantea Dudas de Aplicabilidad

Todd Neale

September 02, 2014

Advertisement

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

美国的女性介入医生依然很罕见

Las Mujeres Intervencionistas Siguen Siendo una Rareza en EE.UU.

Female Interventionalists Remain a Rarity in the United States

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

India Coronary Stent Market to be Tripled by 2021

医保患者接受颈动脉支架置入后的高死亡率可能会影响治疗益处

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

过去十年中避免或经受住急性CVD、卒中的前景大为改善

Outlook for Avoiding or Surviving Acute CVD, Stroke Much Improved Over Past Decade

MI患者的低试验参与率引起了对适用性的质疑

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

El Bajo Índice de Participación del Ensayo de Pacientes IM Plantea Dudas de Aplicabilidad

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content